The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 08, 2022
Filed:
Jan. 19, 2021
Applicant:
Eli Lilly and Company, Indianapolis, IN (US);
Inventors:
Qing Chai, San Diego, CA (US);
Jonathan Wesley Day, Indianapolis, IN (US);
Robert John Konrad, Carmel, IN (US);
Yuewei Qian, Carmel, IN (US);
Oliver Schroeder, Encinitas, CA (US);
Robert William Siegel, Fountaintown, IN (US);
Assignee:
Eli Lilly and Company, Indianapolis, IN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/22 (2006.01); A61P 3/00 (2006.01); A61B 5/021 (2006.01); A61B 5/024 (2006.01); A61B 5/05 (2021.01); A61B 5/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/22 (2013.01); A61B 5/02125 (2013.01); A61B 5/02438 (2013.01); A61B 5/02444 (2013.01); A61B 5/05 (2013.01); A61B 5/681 (2013.01); A61B 5/6843 (2013.01); A61P 3/00 (2018.01); A61K 2039/505 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract
Angiopoietin-like protein (ANGPTL)3/8 fusion proteins are disclosed. Nucleic acid constructs encoding ANGPTL3/8 fusion proteins also are disclosed. Methods of making and using the same also are disclosed, especially for generating antibodies against ANGPTL3 and/or ANGPTL8.